From October 2022, the work of the NABCOP has been expanded on by two new national audits of primary breast cancer and metastatic breast cancer in women and men of all ages.

Find out more.

Treatment-related acute toxicity with adjuvant systemic treatment for HER2-positive early invasive breast cancer

Treatment-related acute toxicity with adjuvant systemic treatment among patients with HER2-positive early invasive breast cancer: a national population-based cohort study.

Melissa Gannon, David Dodwell, Katie Miller, Jibby Medina, Karen Clements, Kieran Horgan, Min Hae Park, David Cromwell.

Published online: September 4, 2023. BMJ Oncology

View the Journal

DOI: http://dx.doi.org/10.1136/bmjonc-2023-000081